GK

Goldi Kumari

Active Director Director DIN 06811192
DIN 06811192 First appointment Jan 2014 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2014
Shareholding value •••• Premium profile

About Goldi Kumari

Data last updated:

Goldi Kumari is a Director at Sitnez Biocare Private Limited (since 2014). The company operates in Pharma. Sitnez Biocare Private Limited reported revenue of ₹3.07 Cr (FY 2025).

DIN 06811192
Primary Designation Director
Industry Pharma
First Appointment 07 Jan 2014
Oldest Company Age 15 yrs
Largest company Sitnez Biocare Private Limited · ₹3.07 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sitnez Biocare Private Limited U24232CH2011PTC033335
Director07 Jan 20142011₹3.07 Cr (FY 2025)Active

Board colleagues of Goldi Kumari

NameDINCompanyDesignation
Ravi Ranjan02968404Sitnez Biocare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Sitnez Biocare Private Limited
Premium access

Shareholding and investment profile for Goldi Kumari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Goldi Kumari

Goldi Kumari currently holds 1 directorship: Sitnez Biocare Private Limited (Director, since 07 Jan 2014, revenue ₹3.07 Cr (FY 2025)).

Goldi Kumari was first appointed on 07 Jan 2014 as Director at Sitnez Biocare Private Limited.

The current boards of Goldi Kumari's companies include Ravi Ranjan (Sitnez Biocare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available